Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,123.3
-21.0 (-0.67%)

 

  • STI Straits Times Index
    3,123.3
    -21.0 (-0.67%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,582.5
    4.9 (0.31%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,882.3
    -348.7 (-1.24%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,433.7
    -29.1 (-0.84%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,540.8
    -606.7 (-2.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,975.8
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,387.6M
  • Value: 1,468.4M
  • Rise: 151
  • Fall: 160
  • Unch: 465

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.191+0.001
Golden Agri-Res0.275+0.015
Advanced Systems0.001-
Jiutian Chemical0.098+0.003
AP Strategic0.003+0.001
ThaiBev0.695-0.015
Suntec Reit1.490-0.010
Singtel2.410-0.010
Shen Yao0.009-
VCPlus0.028-0.001

World Indices

World Indices
Name Last Change
Nasdaq 13,031.7 -357.7
HSI 27,884.2 -346.9
HSCEI 10,418.8 -137.8
Jakarta 5,975.8
Nikkei 225 27,542.7 -604.8
SSE Comp 3,433.7 -29.1
Shanghai A 3,599.0 -30.5
Shanghai B 248.6 -2.7
KOSPI 3,147.7 -13.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

APPLIED GENETIC TECHNOLOGIES CORP APPLIED GENETIC TECHNOLOGIES CORP
Updated on 12 May 2021 (End of trading day)
Last (USD): 3.760 Change: +0.080 High: 3.960 Remarks: -
Change (%): +2.17 Low: 3.690
Open 3.740 Yesterday's Close 3.6799999999999997
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,142,780 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.07581 Trailing EPS (USD) e -1.32529 NAV (USD) b 0.9734
PE a - Trailing PE f - Price / NAV b 3.8627
Dividend (USD) d - Cash In Hand (USD) g 0.4479 Issued & Paid-up Shares c 42,657,900
Dividend Yield (%) d - Price / Cash In Hand g 8.395 Treasury Shares h 41,000
Market Cap (M) 160.394 Enterprise Value (M) 121.994
Piotroski F Score 0 Exchange Code AGTC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 84.99 Free Float (%) 89.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Nov 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference APPLIED GENETIC TECHNOLOGIES CORP NASDAQ 160.394 - - 3.8627 -
Industry Biotechnology NASDAQ 2,845.857 106.306 106.381 7.3411 0.620
Local Peer AMGEN INC NASDAQ 144,115.380 19.840 20.341 15.4399 2.568
Local Peer GILEAD SCIENCES INC NASDAQ 84,594.441 687.774 281.045 4.4608 4.032
Local Peer MODERNA INC NASDAQ 61,305.295 - 102.489 15.9732 -
Local Peer ILLUMINA INC NASDAQ 54,434.640 82.980 86.404 11.0595 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,055.621 20.303 19.933 6.1307 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,032.709 15.380 13.495 4.5114 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 44,954.304 2,594.870 474.671 - -
Local Peer BIOGEN INC NASDAQ 41,255.081 10.312 13.698 3.8620 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 38,013.058 62.998 55.754 3.0614 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,700.207 - - 7.1684 -
Local Peer SEAGEN INC NASDAQ 26,272.425 42.812 39.767 7.6716 -
Local Peer INCYTE CORPORATION NASDAQ 18,115.058 - 37.860 6.6408 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ARVINAS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), XENCOR INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), INSTIL BIO INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), SEER INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BIOATLA INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), IMMUNOVANT INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALLOVIR INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), PRECIGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ALECTOR INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), AFFIMED N V (NASDAQ), MANNKIND CORPORATION (NASDAQ), MIMEDX GROUP INC (NASDAQ), HUMANIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), EPIZYME INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERUS B V (NASDAQ), PERSONALIS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), NKARTA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ANAPTYSBIO INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AGENUS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), INHIBRX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), COMPUGEN (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), GERON CORP (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), SESEN BIO INC (NASDAQ), ADICET BIO INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCORUS INC (NASDAQ), ATRECA INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVROBIO INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), TREVENA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOVIE INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SAVARA INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), IMV INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INMUNE BIO INC (NASDAQ), INFLARX N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EVOGENE LTD (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), LONGEVERON INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SOLIGENIX INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PALISADE BIO INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 124,816.660 39.797 32.797 11.8115 1.070
Global Peer WUXI BIO HKEx 435,429.272 229.438 229.440 17.8587 -
Global Peer BEIGENE HKEx 225,187.032 - - 7.2348 -
Global Peer SINO BIOPHARM HKEx 153,440.929 49.276 49.277 7.7280 0.898
Global Peer ZAI LAB-SB HKEx 109,834.252 - - 12.1137 -
Global Peer GENSCRIPT BIO HKEx 37,915.382 - - 5.4229 -
Global Peer JOINN HKEx 37,346.161 105.504 82.726 4.7729 0.239
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer KINTOR PHARMA-B HKEx 23,650.171 - - 13.2283 -
Other Global Peers 3SBIO (HKEx), NUVATION BIO INC (NYSE), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), JW THERAP-B (HKEx), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), JHBP-B (HKEx), IMUGENE LIMITED (ASX), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), DPHARMA (Bursa), 22ND CENTURY GROUP INC (NYSE American), ANTEOTECH LIMITED (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), IMMUTEP LTD (ASX), NANOVIRICIDES INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), IBIO INC (NYSE American), BIOMX INC (NYSE American), ENZO BIOCHEM INC (NYSE), KAZIA THERAPEUTICS LIMITED (ASX), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), UNI-BIO GROUP (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), GENETIC TECHNOLOGIES (ASX), CT ENTERPRISE (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), RHINOMED LIMITED (ASX), ORAGENICS INC (NYSE American), PATRYS LIMITED (ASX), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), REGENEUS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.100
-2.59 %
10 Days --0.410
-9.83 %
20 Days --0.290
-7.16 %
Medium Term Return 3 Months --1.390
-26.99 %
6 Months --1.430
-27.55 %
1 Year --0.730
-16.26 %
Long Term Return 2 Years --0.020
-0.53 %
3 Years --1.840
-32.86 %
5 Years --11.910
-76.01 %
Annualised Return Annualised --
-24.83 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.540 - 9.670 Change From 1 Year Low +0.220 % Change From 1 Year Low (%) +6.21
Change From 1 Year High -5.910 % Change From 1 Year High (%) -61.12
2 Years Range 2.290 - 10.420 Change From 2 Years Low +1.470 % Change From 2 Years Low (%) +64.19
Change From 2 Years High -6.660 % Change From 2 Years High (%) -63.92
5 Years Range 2.260 - 17.410 Change From 5 Years Low +1.500 % Change From 5 Years Low (%) +66.37
Change From 5 Years High -13.650 % Change From 5 Years High (%) -78.40
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
12 May 2021 3.740 3.960 3.690 3.760 1,142,780 -
11 May 2021 3.600 3.890 3.590 3.680 935,102 -
10 May 2021 3.890 3.905 3.670 3.810 780,628 -
07 May 2021 3.790 3.913 3.680 3.890 1,359,432 -
06 Ma